The Global Health Observatory

Explore a world of health data

Map
Table
Indicator name:
Availability of medications for opioid dependence
Short name:
Availability of medications for opioid dependence
Data type:
Categorical
Indicator Id:
2550
Topic:
Health systems resources
Definition:
Availability of medications in publicly funded treatment services for the treatment of opioid dependence such as buprenorphine (sublingual tablets), buprenorphine/ naloxone (sublingual tablets), buprenorphine/ naloxone (sublingual film), methadone (tablets), methadone (liquid) or naltrexone or medications for the treatment of opioid withdrawal such as clonidine in tablets or lofexidine in tablets or naloxone for the treatment of opioid overdose.
Method of estimation:
The national authorities of a given country respond to the WHO ATLAS survey on resources for the prevention and treatment of substance use disorders.
Expected frequency of data dissemination:
Periodic
Expected frequency of data collection:
Periodic
Comments:
Other sources of information: WHO (2009). Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva, World Health Organization.
Contact person email:
msb@who.int
Name:
NMH/MSD/MSB
Indicator Metadata Registry List
Availability of naloxone
If you have any feedback, you are welcome to write it here.
If you need to access the old Global Health Observatory data, you can do it here. But before you leave, please provide us your feedback about our new data portal.